Biomea Fusion, Inc. Stock Analysis & AI Score
Biomea Fusion, Inc. (BMEA) has an ST Score of 38.2 (C), driven by its Forecast (A) and held back by its Profitability (F). Analysts rate it Buy with a $20.20 price target (+1255.7% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Biomea Fusion, Inc. (BMEA) has an ST Score of 38.2 (C), driven by its Forecast (A) and held back by its Profitability (F). Analysts rate it Buy with a $20.20 price target (+1255.7% upside).
- Strongest
- ForecastA
- Weakest
- ProfitabilityF
All factor grades
- ForecastA
- MomentumB+
- ValuationB-
- GrowthC-
- Financial StrengthD
- ProfitabilityF
- Piotroski0/9
Contact
BMEA stock: frequently asked questions
What is BMEA's ST Score?
Biomea Fusion, Inc. (BMEA) has an ST Score of 38.2 (C), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is BMEA a buy, hold, or sell?
Analysts rate BMEA a Buy, with a price target of $20.20 (+1255.7% vs the current price). Our ST Score grades it C (38.2/100). The ST Score is a data-driven signal, not a recommendation.
What are BMEA's factor grades?
Valuation B-, Profitability F, Financial Strength D, Momentum B+, Growth C-, Forecast A.
What is BMEA's valuation grade?
Biomea Fusion, Inc. (BMEA) earns a valuation grade of B-, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is BMEA's growth grade?
Biomea Fusion, Inc. (BMEA) earns a growth grade of C-, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is BMEA's profitability grade?
Biomea Fusion, Inc. (BMEA) earns a profitability grade of F, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is BMEA's financial strength grade?
Biomea Fusion, Inc. (BMEA) earns a financial strength grade of D, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for BMEA?
The average analyst price target for Biomea Fusion, Inc. (BMEA) is $20.20 from 13 analysts, which is +1255.7% versus the recent price of $1.49.
What is BMEA's Piotroski score?
Biomea Fusion, Inc. (BMEA) has a Piotroski F-Score of 0 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.